News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Muta M. Issa, MD, MBA

Articles by Muta M. Issa, MD, MBA

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men

ByMuta M. Issa, MD, MBA,Pei-Jung Lin, PhD,Michael T. Eaddy, PharmD, PhD,Manan B. Shah, PharmD, PhD,E. Anne Davis, PharmD, MS

May 1st 2008

A Large Retrospective Analysis of Acute Urinary Retention and Prostate-related Surgery in BPH Patients Treated with 5-alpha Reductase Inhibitors: Dutasteride Versus Finasteride

ByMuta M. Issa, MD, MBA,M. Chris Runken, PharmD,Amy L. Grogg, PharmD,Manan B. Shah, PharmD, PhD

February 1st 2007

Medical Therapy for Benign Prostatic Hyperplasia - Present and Future Impact

ByMuta M. Issa, MD, MBA,Timothy S. Regan, BPharm, RPh, CPh

February 1st 2007

Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate

ByMichael James Naslund, MD, MBA,Muta M. Issa, MD, MBA,Amy L. Grogg, PharmD,Michael T. Eaddy, PharmD, PhD,Libby Black, PharmD

March 1st 2006

An Assessment of the Diagnosed Prevalence of Diseases in Men 50 Years of Age or Older

ByMuta M. Issa, MD, MBA,Thomas C. Fenter, MD,Libby Black, PharmD,Amy L. Grogg, PharmD,Eric J. Kruep, PharmD, MS

March 1st 2006

Latest Updated Articles

Comparative Analysis of Alpha-blocker Utilization in Combination With 5-Alpha Reductase Inhibitors for Enlarged Prostate in a Managed Care Setting Among Medicare-aged Men
Published: May 1st 2008 | Updated:
Clinical and Economic Outcomes in Patients Treated for Enlarged Prostate
Published: March 1st 2006 | Updated:
An Assessment of the Diagnosed Prevalence of Diseases in Men 50 Years of Age or Older
Published: March 1st 2006 | Updated:
A Large Retrospective Analysis of Acute Urinary Retention and Prostate-related Surgery in BPH Patients Treated with 5-alpha Reductase Inhibitors: Dutasteride Versus Finasteride
Published: February 1st 2007 | Updated:
Medical Therapy for Benign Prostatic Hyperplasia - Present and Future Impact
Published: February 1st 2007 | Updated:

Trending on AJMC

FDA Approves Sibeprenlimab for Immunoglobulin A Nephropathy

Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS

Faricimab Brought Early Control of Some Symptoms in AMD

Patients Face New Care Complexities as DTC Options Expand

Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.